Veraxa Biotech AG - Ordinary Shares (NQ:VRXA)Price and VolumeDetailed Quote
Top NewsMore NewsPerformance
52-Week Range
95.8% below 52-week high
1.154
1.0452W Low
27.3652W High
1 Week
18.1% below 1-week high
1.041W Low
1.411W High
Veraxa Biotech AG - Ordinary Shares (VRXA) traded between $1.04 and $27.36 over the past 52 weeks and last traded at $1.15, 95.8% below its 52-week high. Over the past week it ranged between $1.04 and $1.41.
Past 12 Months
1W
+$0.02
1M
-$0.50
3M
-$0.99
6M
-$23.64
YTD
-$23.64
1Y
-$23.64
VRXA was -95.3% over the past year, -95.3% over six months, -95.3% year to date, +2.1% in the last week.
12 Months vs Market
VRXA
DIA
SPY
QQQ
IWM
Over the past 12 months VRXA returned -95.3% versus DIA (Dow) +12.4%, SPY (S&P 500) +17.3%, QQQ (Nasdaq 100) +23.9% and IWM (Russell 2000) +13.8%.
Volume & Liquidity
0.46× 3-mo avg
Today 132,455
3-mo avg 288.7K
1W
1M
3M
6M
YTD
1Y
VRXA most recently traded 132,455 shares against a 3-month average daily volume of 288.7K. More NewsRead More
These stocks are moving in today's session ↗
September 04, 2026
VERAXA Biotech Appoints Raju Willener as Chief Financial Officer
September 04, 2026
Frequently Asked QuestionsIs Veraxa Biotech AG - Ordinary Shares publicly traded?
Yes, Veraxa Biotech AG - Ordinary Shares is publicly traded.
What exchange does Veraxa Biotech AG - Ordinary Shares trade on?
Veraxa Biotech AG - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Veraxa Biotech AG - Ordinary Shares?
The ticker symbol for Veraxa Biotech AG - Ordinary Shares is VRXA on the Nasdaq Stock Market
What is the current price of Veraxa Biotech AG - Ordinary Shares?
The current price of Veraxa Biotech AG - Ordinary Shares is 1.154
When was Veraxa Biotech AG - Ordinary Shares last traded?
The last trade of Veraxa Biotech AG - Ordinary Shares was at 10/12/26 01:28 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
